Equity Research, Broker Reports, and media content on CYNAPSUS THERAPEUTICS INC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about CYNAPSUS THERAPEUTICS INC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on CYNAPSUS THERAPEUTICS INC. We currently have 0 research reports from 0 professional analysts.

Open
0.00
Volume
0.0m
Range
0.00/0.00
Market Cap
0m
52 Week
14.0/53.7
Date Source Announcement
29Aug16 11:00 GNW Cynapsus Receives FDA Fast Track Designation for APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease
15Aug16 11:00 GNW Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allowing for At-Home Titration
12Aug16 11:00 GNW Cynapsus Announces Publication in the Journal Movement Disorders of Data for the Treatment of OFF Episodes in Patients with Parkinson's Disease
10Aug16 21:10 GNW Cynapsus Therapeutics Reports Second Quarter 2016 Financial Results and Recent Developments
18Jul16 21:10 GNW Cynapsus Therapeutics Provides European Clinical Update for APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease
18Jul16 21:10 GNW Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease
06Jul16 11:00 GNW Cynapsus Therapeutics Announces 2016 Analyst and Investor Day
  • Frequency of research reports

     

  • Research reports on

    CYNAPSUS THERAPEUTICS INC

  • Providers covering

    CYNAPSUS THERAPEUTICS INC